Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2024-07-12
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, monitoring changes in body composition (LM, FM, and PhA) and indirect indices (lean mass index and fat mass index) using BIA, together with monitoring changes in BMR and physical activity level, could provide important support for the continuous control and definition of the clinical stage of the disease in patients with AN.
The aim of this study is to determine body composition, basal metabolic rate, and level of physical activity in Anorexia Nervosa and normal weight subjects to identify the most consistent parameters to define the clinical stage of the disease in subjects with AN.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Body Schema Distortion on Remission and Weight Regain in Anorexia Nervosa
NCT05682417
Exploring the Changes in Social Interaction and Its Protective Features in Anorexia Nervosa
NCT06439160
Relapse in Anorexia Nervosa. A Cohort Study
NCT04046926
Incomplete Total Body Protein Recovery in Adolescent Patients With Anorexia Nervosa
NCT03334032
Characteristics and Importance of Physical Activity in Women With Anorexia Nervosa
NCT00917423
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore, monitoring changes in body composition (LM, FM, and PhA) and indirect indices (lean mass index and fat mass index) using BIA, together with monitoring changes in BMR and physical activity level, could provide important support for the continuous control and definition of the clinical stage of the disease in patients with AN.
The aim of this study is to determine body composition, basal metabolic rate, and level of physical activity in Anorexia Nervosa and normal weight subjects to identify the most consistent parameters to define the clinical stage of the disease in subjects with AN.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anorexia Nervosa (AN)
Female adolescents with Anorexia Nervosa
Collection of anthropometric and biochemical parameters
Collection of anthropometric parameters biochemical parameters basal metabolic rate body composition questionnaires
Normal weight
Female normal weight adolescents
Collection of anthropometric and biochemical parameters
Collection of anthropometric parameters biochemical parameters basal metabolic rate body composition questionnaires
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Collection of anthropometric and biochemical parameters
Collection of anthropometric parameters biochemical parameters basal metabolic rate body composition questionnaires
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age range: 12-18 years
* Anorexia nervosa
* Hospitalized at the Division of Auxologia, San Giuseppe Hospital, Istituto Auxologico Italiano, IRCCS, Piancavallo, Italy
* Female sex
* Age range: 12-18 years
* Normal weight
Exclusion Criteria
Adolescents with normal weight:
* Absence of signed informed consent
12 Years
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Auxologico Italiano
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto Auxologico Italiano IRCCS, Site Piancavallo
Oggebbio, Verbania, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01C409
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.